Mutations in IDH genes, observed at high frequencies in diffuse astrocytomas, oligodendrogliomas and secondary glioblastomas, have a specific metabolic profile, a hypermethylated phenotype and a better prognosis [5]. The gene discussed is IDH1; the disease is glioblastoma.